August 2, 2020

“We Need to Move On” from Hydroxychloroquine, Says Trump’s Testing Czar

Adm. Brett Giroir, assistant secretary of Health and Human Services.Alex Brandon/AP

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

The country’s coronavirus testing czar on Sunday tried to put the endless debate over hydroxychloroquine, the president’s preferred coronavirus treatment, to bed. “We need to move on from that and talk about what is effective,” said Brett Giroir, assistant secretary at the Department of Health and Human Services, on NBC’s Meet the Press—contradicting his boss, who is still touting the drug.

For months, President Trump has hyped the anti-malarial drug hydroxychloroquine as a treatment for COVID-19. At one point, Trump even claimed he was taking the drug himself. This past week, Trump’s son Donald Trump Jr. tweeted a viral video showing doctors saying masks are not necessary and that hydroxychloroquine was a proven antidote. Twitter and Facebook took the video down for spreading misinformation, and Twitter suspended Trump Jr.’s ability to tweet for 12 hours. Trump, who also tweeted the video, defended his support of hydroxychloroquine after the video was removed, and said the doctors in the viral video were “very respected.” One of the featured doctors, Stella Immanuel, holds numerous unproven beliefs, including about sex with demons.

Despite Trump’s protestations, Dr. Anthony Fauci said on Wednesday that hydroxychloroquine is not effective. “We know that every single good study—and by good study I mean randomized control study in which the data are firm and believable—has shown that hydroxychloroquine is not effective in the treatment of Covid-19,” he said.

On Sunday, Giroir piled on. “There may be circumstances, I don’t know what they are, where a physician may prescribe it for an individual, but I think most physicians and prescribers are evidence-based and they’re not influenced by whatever is on Twitter or anything else,” he said. “And the evidence just doesn’t show that hydroxychloroquine is effective right now.”

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate